Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis

Journal of Pediatrics

Volumn 178, Issue , 2016, Pages 206-213

  Gounder, Prabhu P ^a   Bulkow, Lisa R ^b   Snowball, Mary ^c   Negus, Susan ^b   Spradling, Philip R ^c   McMahon, Brian J ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cancer screening; cohort study; diagnosis; epidemiology; incidence study

Indexed keywords

ALPHA FETOPROTEIN; INTERFERON; NUCLEOSIDE ANALOG;

ADULT; ALASKA NATIVE; ALPHA FETOPROTEIN BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; YOUNG ADULT; COMPLICATION; ETHNOLOGY; GENETICS; HEPATITIS B VIRUS; INCIDENCE; LIVER TUMOR; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADULT; ALASKA NATIVES; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHILD; COHORT STUDIES; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84994096902     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.08.017     Document Type: Article

References (25)

1. 1 Goldstein, S.T., Zhou, F., Hadler, S.C., Bell, B.P., Mast, E.E., Margolis, H.S., A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 (2005), 1329–1339.
2. 2 Bruix, J., Sherman, M., American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53 (2011), 1020–1022.
3. 3 Wasley, A., Kruszon-Moran, D., Kuhnert, W., Simard, E.P., Finelli, L., McQuillan, G., et al. The prevalence of Hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202 (2010), 192–201.
4. 4 McMahon, B.J., Rhoades, E.R., Heyward, W.L., Tower, E., Ritter, D., Lanier, A.P., et al. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet 2 (1987), 1134–1136.
5. 5 McMahon, B.J., Bulkow, L., Harpster, A., Snowball, M., Lanier, A., Sacco, F., et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 32 (2000), 842–846.
6. 6 McMahon, B.J., Holck, P., Bulkow, L., Snowball, M., Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 135 (2001), 759–768.
7. 7 McMahon, B.J., Natural history of chronic hepatitis B. Clin Liver Dis 14 (2010), 381–396.
8. 8 Ching, L.K., Gounder, P.P., Bulkow, L., Spradling, P.R., Bruce, M., Negus, S., et al. Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people. Liver Int, 2016, 10.1111/liv.13129.
9. 9 Livingston, S.E., Simonetti, J.P., McMahon, B.J., Bulkow, L.R., Hurlburt, K.J., Homan, C.E., et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195 (2007), 5–11.
10. 10 Ott, J.J., Stevens, G.A., Groeger, J., Wiersma, S.T., Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30 (2012), 2212–2219.
11. 11 Kelly, J., Schade, T., Starkey, B., White, S., Ashokkumar, R., Lanier, A., Cancer in Alaska. 1969-2008 40-Year Report. Anchorage, AK: Alaska Native Tribal Health Consortium, Alaska Native Epidemiology Center, 2012.
12. 12 Surveillance, Epidemiology, and End Results (SEER) Program, About the SEER registries: National Cancer Institute Surveillance Research Program. http://seer.cancer.gov/registries/ Accessed July 15, 2015.
13. 13 Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996), 693–699.
14. 14 Zhang, B.H., Yang, B.H., Tang, Z.Y., Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004), 417–422.
15. 15 Yeh, Y.P., Hu, T.H., Cho, P.Y., Chen, H.H., Yen, A.M., Chen, S.L., et al. Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan. Hepatology 59 (2014), 1840–1849.
16. 16 Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134 (2008), 1908–1916.
17. 17 Llovet, J.M., Fuster, J., Bruix, J., Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30 (1999), 1434–1440.
18. 18 Roman, S., Jose-Abrego, A., Fierro, N.A., Escobedo-Melendez, G., Ojeda-Granados, C., Martinez-Lopez, E., et al. Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol 20 (2014), 7181–7196.
19. 19 Kramvis, A., Kew, M., Francois, G., Hepatitis B virus genotypes. Vaccine 23 (2005), 2409–2423.
20. 20 Beasley, R.P., Hwang, L.Y., Lin, C.C., Chien, C.S., Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 (1981), 1129–1133.
21. 21 Chen, C.J., Yang, H.I., Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 26 (2011), 628–638.
22. 22 McMahon, B.J., Alward, W.L., Hall, D.B., Heyward, W.L., Bender, T.R., Francis, D.P., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 (1985), 599–603.
23. 23 Livingston, S.E., Simonetti, J.P., Bulkow, L.R., Homan, C.E., Snowball, M.M., Cagle, H.H., et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 133 (2007), 1452–1457.
24. 24 Estroff, D.T., Greenman, J.A., Heyward, W.L., McMahon, B.J., Hardison, H.H., Bender, T.R., Fortuine, R., (eds.) Increased prevalence of hepatitis B surface antigen in pregnant Alaska Eskimos, 1985, University of Washington Press, Seattle, Washington USA.
25. 25 Croswell, J.M., Ransohoff, D.F., Kramer, B.S., Principles of cancer screening: lessons from history and study design issues. Semin Oncol 37 (2010), 202–215.